Dr. Rushing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 Barnhill Dr
Rt473
Indianapolis, IN 46202Phone+1 317-948-8310Fax+1 317-944-3646
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1979 - 1981
- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1979
- University of Illinois College of MedicineClass of 1976
Certifications & Licensure
- IL State Medical License 1977 - Present
- IN State Medical License 2000 - 2023
- WI State Medical License 1981 - 2001
- MN State Medical License 1979 - 1981
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
- A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
Publications & Presentations
PubMed
- 14 citationsA phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.Steven Attia, Vanessa Bolejack, Kristen N Ganjoo, Suzanne George, Mark Agulnik
Cancer Medicine. 2023-01-01 - 14 citationsA Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the...Richard F. Riedel, Karla V. Ballman, Yao Lu, Steven Attia, Elizabeth T. Loggers
The Oncologist. 2020-11-01 - 2 citationsPharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.Victor M. Villalobos, Gary Mo, Mark Agulnik, Seth M. Pollack, Daniel A. Rushing
Cancer Medicine. 2020-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: